Foxp3 depends on Ikaros for control of regulatory T cell gene expression and function

  1. Department of Pathology, Perelman School of Medicine at the University of Pennsylvania and The Children’s Hospital of Philadelphia
  2. Center for Spatial and Functional Genomics, The Children’s Hospital of Philadelphia
  3. Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania and The Children’s Hospital of Philadelphia

Editors

  • Reviewing Editor
    Apurva Sarin
    Institute for Stem Cell Science and Regenerative Medicine, Bangalore, India
  • Senior Editor
    Satyajit Rath
    Indian Institute of Science Education and Research (IISER), Pune, India

Joint Public Review:

This study investigates the role of Ikaros, a zinc finger family transcription factor related to Helios and Eos, in T-regulatory (Treg) cell functionality in mice. Through genome-wide association studies and chromatin accessibility studies, the authors find that Ikaros shares similar binding sites to Foxp3. Ikaros cooperates with Foxp3 to establish a major portion of the Treg epigenome and transcriptome. Ikaros-deficient Treg exhibits Th1-like gene expression with abnormal expression of IL-2, IFNg, TNFa, and factors involved in Wnt and Notch signalling. Further, two models of inflammatory/ autoimmune diseases - Inflammatory Bowel Disease (IBD) and organ transplantation - are employed to examine the functional role of Ikaros in Treg-mediated immune suppression. The authors provide a detailed analysis of the epigenome and transcriptome of Ikaros-deficient Treg cells.

These studies establish Ikaros as a factor required in Treg for tolerance and the control of inflammatory immune responses. The data are of high quality. Overall, the study is well organized, and reports new data consolidating mechanistic aspects of Foxp3 mediated gene expression program in Treg cells.

Strengths:
The authors have performed biochemical studies focusing on mechanistic aspects of molecular functions of the Foxp3-mediated gene expression program and complemented these with functional experiments using two models of autoimmune diseases, thereby strengthening the study. The studies are comprehensive at both the cellular and molecular levels. The manuscript is well organized and presents a plethora of data regarding the transcriptomic landscape of these cells.

Weakness:
The authors claim that the mice have no pathologic signs of autoimmune disease even at a relatively old age, yet mice have an increased number of activated CD4+ T cells and T-follicular helper cells (even at the age of 6 weeks) as well as reduced naïve T-cells. Thus, immune homeostasis is perturbed in these mice even at a young age and the effect of inflammatory microenvironments on cellular functions cannot be ruled out. Further, clear conclusions from the genome-wide studies are lacking.

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation